Repair of Ischemic Injury by Pluripotent Stem Cell Based Cell Therapy without Teratoma through Selective Photosensitivity-Reference-Cited by-同舟云学术

Repair of Ischemic Injury by Pluripotent Stem Cell Based Cell Therapy without Teratoma through Selective Photosensitivity

Published:2015-12 Issue:6 Volume:5 Page:1067-1080
ISSN:2213-6711
Container-title:Stem Cell Reports
language:en
Short-container-title:Stem Cell Reports

Author:

Cho Seung-Ju,Kim So-Yeon,Jeong Ho-Chang,Cheong Hyeonsik,Kim Doseok,Park Soon-Jung,Choi Jong-Jin,Kim Hyongbum,Chung Hyung-Min,Moon Sung-Hwan,Cha Hyuk-Jin

Funder

National Research Foundation of Korea

Korea Health Industry Development Institute

Publisher

Elsevier BV

Subject

Cell Biology,Developmental Biology,Genetics,Biochemistry

Reference44 articles.

1. Neurally selected embryonic stem cells induce tumor formation after long-term survival following engraftment into the subretinal space;Arnhold;Invest. Ophthalmol. Vis. Sci.,2004

2. Cell therapy with embryonic stem cell-derived cardiomyocytes encapsulated in injectable nanomatrix gel enhances cell engraftment and promotes cardiac repair;Ban;ACS Nano,2014

3. Cell therapy for cardiac repair--lessons from clinical trials;Behfar;Nat. Rev. Cardiol.,2014

4. Selective elimination of human pluripotent stem cells by an oleate synthesis inhibitor discovered in a high-throughput screen;Ben-David;Cell Stem Cell,2013

5. Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson’s disease: effect of in vitro differentiation on graft survival and teratoma formation;Brederlau;Stem Cells,2006

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stem cell-based therapy in cardiac repair after myocardial infarction: Promise, challenges, and future directions;Journal of Molecular and Cellular Cardiology;2024-03

2. Verification of Therapeutic Effect through Accelerator Mass Spectrometry‐Based Single Cell Level Quantification of hESC‐Endothelial Cells Distributed into an Ischemic Model;Advanced Healthcare Materials;2023-05

3. Still finding ways to augment the existing management of acute and chronic kidney diseases with targeted gene and cell therapies: Opportunities and hurdles;Frontiers in Medicine;2023-03-07

4. Scalable manufacturing of clinical‐grade differentiated cardiomyocytes derived from human‐induced pluripotent stem cells for regenerative therapy;Cell Proliferation;2022-05-09

5. Acute multidrug delivery via a wearable bioreactor facilitates long-term limb regeneration and functional recovery in adult Xenopus laevis;Science Advances;2022-01-28